EDWARD T. ZAWADA JR., M.D.; LESLIE DORNFELD, M.D.; MORTON MAXWELL, M.D.; LEONARD MARKS, M.D.; JOSEPH J. KAUFMAN, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Although a severe delayed hypertensive crisis has been reported in a patient with a pheochromocytoma after saralasin infusion (1) we have seen a patient with both renovascular hypertension and an extra-adrenal pheochromocytoma who had only a sustained vasodepressor response to saralasin.
A 10-year-old white boy presented with sudden onset of severe headaches and hypertension in February 1976. Blood pressure was 210/130 mm Hg. Fundi were grade II. Heart and lung examination findings were unremarkable except for sinus tachycardia. A 24-h urine contained 7.9 mg of vanillylmandelicacid (normal range, 1 to 10 mg) and 226 mg of catecholamines
ZAWADA ET, DORNFELD L, MAXWELL M, et al. Pheochromocytoma and Vasodepressor Response to Saralasin. Ann Intern Med. 1979;91:494–495. doi: 10.7326/0003-4819-91-3-494_3
Download citation file:
Published: Ann Intern Med. 1979;91(3):494-495.
Adrenal Disorders, Endocrine and Metabolism, Endocrine Cancer, Hematology/Oncology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use